Cargando…
Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
MicroRNAs (miRNAs) are a group of small non-coding RNAs with approximately 19–25 nucleotides that are involved in regulating a range of developmental and physiological processes. Non-exosomal circulating and exosomal miRNAs have also been proposed to be useful in diagnostics as biomarkers for diseas...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984169/ https://www.ncbi.nlm.nih.gov/pubmed/32038230 http://dx.doi.org/10.3389/fphar.2019.01500 |
_version_ | 1783491610020937728 |
---|---|
author | Nik Mohamed Kamal, Nik Nur Syazana Binti Shahidan, Wan Nazatul Shima |
author_facet | Nik Mohamed Kamal, Nik Nur Syazana Binti Shahidan, Wan Nazatul Shima |
author_sort | Nik Mohamed Kamal, Nik Nur Syazana Binti |
collection | PubMed |
description | MicroRNAs (miRNAs) are a group of small non-coding RNAs with approximately 19–25 nucleotides that are involved in regulating a range of developmental and physiological processes. Non-exosomal circulating and exosomal miRNAs have also been proposed to be useful in diagnostics as biomarkers for diseases and different types of cancer. In this review, the quantity of miRNAs and of reliable experimental data analyses of miRNAs that come from exosomal and non-exosomal sources are discussed from the perspective of their use as biomarkers for cancer and other diseases, including viral infections, nervous system disorders, cardiovascular disorders, and diabetes. We summarize other research findings regarding the use of miRNA from these two sources as biomarkers in diagnostics and clinical use. The challenges in using miRNA from these two sources in cancer and disease diagnostics are evaluated and discussed. Validation of specific miRNA signatures as biomarkers is a critical milestone in diagnostics. |
format | Online Article Text |
id | pubmed-6984169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69841692020-02-07 Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers? Nik Mohamed Kamal, Nik Nur Syazana Binti Shahidan, Wan Nazatul Shima Front Pharmacol Pharmacology MicroRNAs (miRNAs) are a group of small non-coding RNAs with approximately 19–25 nucleotides that are involved in regulating a range of developmental and physiological processes. Non-exosomal circulating and exosomal miRNAs have also been proposed to be useful in diagnostics as biomarkers for diseases and different types of cancer. In this review, the quantity of miRNAs and of reliable experimental data analyses of miRNAs that come from exosomal and non-exosomal sources are discussed from the perspective of their use as biomarkers for cancer and other diseases, including viral infections, nervous system disorders, cardiovascular disorders, and diabetes. We summarize other research findings regarding the use of miRNA from these two sources as biomarkers in diagnostics and clinical use. The challenges in using miRNA from these two sources in cancer and disease diagnostics are evaluated and discussed. Validation of specific miRNA signatures as biomarkers is a critical milestone in diagnostics. Frontiers Media S.A. 2020-01-20 /pmc/articles/PMC6984169/ /pubmed/32038230 http://dx.doi.org/10.3389/fphar.2019.01500 Text en Copyright © 2020 Nik Mohamed Kamal and Shahidan http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Nik Mohamed Kamal, Nik Nur Syazana Binti Shahidan, Wan Nazatul Shima Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers? |
title | Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers? |
title_full | Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers? |
title_fullStr | Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers? |
title_full_unstemmed | Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers? |
title_short | Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers? |
title_sort | non-exosomal and exosomal circulatory micrornas: which are more valid as biomarkers? |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984169/ https://www.ncbi.nlm.nih.gov/pubmed/32038230 http://dx.doi.org/10.3389/fphar.2019.01500 |
work_keys_str_mv | AT nikmohamedkamalniknursyazanabinti nonexosomalandexosomalcirculatorymicrornaswhicharemorevalidasbiomarkers AT shahidanwannazatulshima nonexosomalandexosomalcirculatorymicrornaswhicharemorevalidasbiomarkers |